Skip to main content

Table 1 Summary statistics of all variables of bladder, prostate and kidney cancer

From: The relationship between urologic cancer outcomes and national Human Development Index: trend in recent years

 

2012

2018

Cancer type

HDI

ASI

MIR

Survival

HDI

ASI

MIR

Survival

prostate

0.669/0.702 (0.519–0.805)

41.0/35.4 (16.2–58.3)

0.542/0.543 (0.338–0.777)

82.2/87.3

(76.6–91.1)

0.705/0.735 (0.582–0.826)

38.7/35.2 (15.8–55.8)

0.432/0.434 (0.276–0.606)

84.1/88.2

(80.6–91.4)

bladder

5.32/3.2

(1.90–7.95)

0.473/0.444

(0.347–0.631)

NA

5.31/3.00

(1.90–8.13)

0.497/0.497

(0.344–0.643)

NA

kidney

4.05/2.60

(1.20–6.05)

0.582/0.604

(0.386–0.780)

NA

4.04/2.30

(1.19–6.43)

0.518/0.492

(0.360–0.684)

NA

  1. The statistics are presented as mean/median (inter quartile range). HDI, Human Development Index. ASI: Age-Standardized Incidence. MIR, Mortality-to-Incidence Ratio